spot_img

Analyst Ratings

HomeCompany NewsAnalyst Ratings

Zymeworks stock price target raised to $40 from $30 at Stifel after trial success

Zymeworks stock price target raised to $40 from $30 at Stifel after trial success

― Advertisement ―

spot_img

Zymeworks stock price target raised to $40 from $30 at Stifel after trial success

Zymeworks stock price target raised to $40 from $30 at Stifel after trial success

More News

Zymeworks stock price target raised to $40 from $30 at Stifel after trial success

Zymeworks stock price target raised to $40 from $30 at Stifel after trial success
spot_img

Explore more

Zymeworks stock price target raised to $40 from $30 at Stifel after trial success

Zymeworks stock price target raised to $40 from $30 at Stifel after trial success